Nu Skin Enterprises, Inc. (NYSE:NUS) Shares Purchased by D.A. Davidson & CO.

D.A. Davidson & CO. increased its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 31.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,925 shares of the company’s stock after purchasing an additional 2,400 shares during the period. D.A. Davidson & CO.’s holdings in Nu Skin Enterprises were worth $422,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of NUS. Advisor Group Inc. grew its stake in shares of Nu Skin Enterprises by 27.9% during the second quarter. Advisor Group Inc. now owns 1,641 shares of the company’s stock worth $80,000 after purchasing an additional 358 shares in the last quarter. Exane Derivatives purchased a new stake in Nu Skin Enterprises in the second quarter valued at $82,000. Machina Capital S.A.S. purchased a new stake in Nu Skin Enterprises in the second quarter valued at $84,000. Meeder Asset Management Inc. lifted its position in Nu Skin Enterprises by 917.4% in the third quarter. Meeder Asset Management Inc. now owns 2,401 shares of the company’s stock valued at $102,000 after acquiring an additional 2,165 shares during the last quarter. Finally, Point72 Asset Management L.P. purchased a new stake in Nu Skin Enterprises in the second quarter valued at $123,000. Hedge funds and other institutional investors own 72.09% of the company’s stock.

In related news, insider Foulis Greg 500,000 shares of the firm’s stock in a transaction on Wednesday, November 6th. 3.20% of the stock is currently owned by corporate insiders.

Shares of NUS opened at $39.08 on Tuesday. Nu Skin Enterprises, Inc. has a 1-year low of $35.03 and a 1-year high of $69.79. The stock has a market cap of $2.17 billion, a PE ratio of 11.10, a price-to-earnings-growth ratio of 1.36 and a beta of 0.75. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.24. The firm has a fifty day moving average price of $42.40 and a 200 day moving average price of $44.85.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Tuesday, November 5th. The company reported $0.79 EPS for the quarter, beating analysts’ consensus estimates of $0.76 by $0.03. Nu Skin Enterprises had a net margin of 4.59% and a return on equity of 23.52%. The business had revenue of $590.00 million during the quarter, compared to analysts’ expectations of $605.02 million. During the same period in the prior year, the company earned $0.94 earnings per share. The business’s revenue was down 13.9% compared to the same quarter last year. As a group, equities analysts expect that Nu Skin Enterprises, Inc. will post 3.1 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 11th. Stockholders of record on Friday, November 29th will be issued a $0.37 dividend. The ex-dividend date is Wednesday, November 27th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 3.79%. Nu Skin Enterprises’s payout ratio is 42.05%.

A number of brokerages recently weighed in on NUS. ValuEngine raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Citigroup cut shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating in a research report on Wednesday, November 6th. Pivotal Research reissued a “buy” rating and issued a $70.00 price target on shares of Nu Skin Enterprises in a research report on Wednesday, August 7th. Stifel Nicolaus raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and boosted their price target for the company from $38.50 to $45.00 in a research report on Tuesday, October 29th. Finally, Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating and set a $44.00 price target for the company. in a research report on Monday, November 11th. Two analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $50.63.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Featured Article: What is the definition of arbitrage?

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.